|
|
|
Name
|
Alexion Pharmaceuticals Inc. |
|
Address:
|
352 Knotter Dr.
|
|
City:
|
Cheshire
|
|
State:
|
CT
|
|
Zip:
|
06410
|
|
Phone
|
203-272-2596
|
|
Web
Site:
|
www.alexionpharmaceuticals.com
|
|
Fax:
|
271-8199
|
|
No. Employees
|
207
|
|
No. Researchers
|
58
|
|
Capitalization
|
$620,370,000
|
|
R&D Spending
|
$60,000,000
|
|
Major Investors
|
Public Co.
|
|
Strategic Alliances
|
Procter & Gamble
Pharmaceuticals
|
|
Products
|
Immunoregulatory therapeutics
|
|
CFO
|
Carsten Boess
|
|
Chief Scientific Research Officer
|
Stephen Squinto
|
|
Ownership
|
Public (NASDAQ: ALXN)
|
|
CEO
|
Leonard Bell
|
|
Year Founded
|
1992
|
|
President
|
David Keiser
|
|
|
|
|
|
|
|
Human Resource Manager/Director
|
Monique Heiler
|
|
|
